Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate.

Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate. Patients ...

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...

According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Drinking tea and coffee could lead to improved cancer outcomes for patients, thanks to the beverages potentially playing a “protective role” against the disease. Specifically, high coffee and/or tea ...

New York City-based Icahn School of Medicine at Mount Sinai has developed an artificial intelligence-powered image analysis tool, MARQO, to accelerate cancer tissue processing. The tool works by ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 trial.

2025 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily-- Current study results on Cancer have been published. According to news reporting from Taoyuan, ...